Skip to main content
. 2022 Feb;12(2):1004–1019. doi: 10.21037/qims-21-705

Table 1. Comparison of general clinical data between the MS group and healthy control group.

Clinical data MS group (n=82) Control group (n=32) P value
Age, years 37.8±14.1 38.3±12.8 0.851
Gender, male 35 (42.7%) 9 (28.4%) 0.151
Hypertension 18 (22%) 5 (15.6%) 0.449
Diabetes mellitus 6 (7.3%) 2 (3.6%) 1.000
Hyperlipidemia 4 (4.7%) 0 (0%) 0.575
Smoking 15 (18.3%) 1 (3.1%) 0.073
Drinking 4 (4.9%) 0 (0%) 0.575
Admission due to EDSS 2.5 [2–4]
Duration of disease (months) 13.5 (1–51.75)

MS, multiple sclerosis; EDSS, extended disability status scale.